Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
Clinical trial NCT00653055 · COMPLETED
Trial details
- NCT number
- NCT00653055
- Sponsor
- Par Pharmaceutical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2001-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.